Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...

New insights into the structures of glutamate receptor ion channels (iGluRs), combined with functional and biochemical data, can help us to understand how agonist binding triggers their activation and ...